Catalyst Wire Dossier Catalyst Wire Dossier

AMG 337

· NantPharma, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AMG 337, covering 2017-07-02 to 2024-05-24. Get the full timeline:

Most recent: Clinical Trial Update: QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma [Phase 2]

See pricing